Quest Diagnostics to Host Investor Day on March 19, 2025

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) has announced plans to host an Investor Day event on March 19, 2025 at the New York Stock Exchange. The event will feature presentations from key executives including Chairman, CEO and President Jim Davis, and Executive Vice President and CFO Sam Samad.

The leadership team will provide institutional investors and financial analysts with insights into several key areas including:

• Updated perspectives on the U.S. laboratory market
• Company's business strategy
• Capital deployment priorities
• Long-term outlook

The event requires advance registration and will be accessible via live webcast on Quest Diagnostics' Investor Relations website. An archived version of the webcast will be made available following the event's conclusion.

SECAUCUS, N.J., Feb. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March 19, 2025 at the New York Stock Exchange. 

During the event, Jim Davis, Chairman, CEO and President, Sam Samad, Executive Vice President and CFO, and other senior executives will provide updated views of the U.S. laboratory market, and the company's business strategy, capital deployment priorities, and its long-term outlook. Advance registration is required.

To register for the event, please go to: Quest Diagnostics 2025 Investor Day Registration.

A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website. 

An archived copy of the webcast will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-19-2025-302376570.html

SOURCE Quest Diagnostics

FAQ

When and where is Quest Diagnostics (DGX) hosting its 2025 Investor Day?

Quest Diagnostics is hosting its Investor Day on Thursday, March 19, 2025, at the New York Stock Exchange.

What topics will be covered at Quest Diagnostics' 2025 Investor Day?

The event will cover updates on the U.S. laboratory market, business strategy, capital deployment priorities, and the company's long-term outlook.

How can investors access Quest Diagnostics' (DGX) 2025 Investor Day presentation?

Investors can access the event through advance registration and a live webcast on Quest Diagnostics' Investor Relations website. An archived version will be available after the event.

Which executives will present at Quest Diagnostics' 2025 Investor Day?

Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and CFO, along with other senior executives will present at the event.